Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6 Year Follow up Study

NCT04646252 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT04646252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04646252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6 Year Follow up Study
Lead sponsor
University of Athens
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2013
Completion date
May 28, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial stiffness, endothelial dysfunction